The European Institute for Biomedical Imaging Research

What The European Institute for Biomedical Imaging Research does

EIBIR is a Vienna-based, non-profit research coordination organization (gemeinnützige GmbH) founded in 2006 and established by the European Society of Radiology (ESR). Rather than developing proprietary technology, it acts as a pan-European umbrella body that coordinates, manages, and disseminates EU-funded biomedical imaging research projects. Its portfolio of 14+ active projects spans AI in cancer imaging, photonics-based ultrasound, lung cancer screening, clinical audit, radiation safety, and intraoperative imaging, with combined grant funding exceeding €40 million from Horizon Europe, EU4Health, IHI, and direct European Commission contracts. Core infrastructure includes the Cancer Image Europe federated platform (under EUCAIM, €17.8M) targeting over 60 million anonymized cancer images, alongside research outputs like AI-POD's cardiovascular decision-support system, SOLACE's lung cancer screening toolkit, and the HyperProbe intraoperative brain imaging system.

EIBIR monetizes through two streams: (1) EU grant funding — EIBIR acts as coordinator or partner and draws an administrative/coordination share from each consortium's budget, and (2) recurring annual Network Service Packages and Industry Service Packages (Active/Regular/Associate tiers) sold to academic and industry members, auto-renewed unless terminated by June 30. It serves a horizontal customer base of 50+ network member institutions across 19 European countries plus Israel, including Medical University Vienna, Erasmus MC, Netherlands Cancer Institute, University College Dublin, and Weizmann Institute. Go-to-market is community-led: EIBIR leverages ESR's annual European Congress of Radiology (ECR), the ESR Connect platform, LinkedIn/Twitter, newsletters, and dedicated webinar series rather than outbound sales. Major industry partners include Philips, Quantum Surgical, and IGEA via the PreciseOnco consortium. Pricing is not publicly disclosed, and EIBIR reports no revenue figures publicly.

Name

The European Institute for Biomedical Imaging Research

Legal name

EIBIR gemeinnützige GmbH

Website

https://eibir.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

EIBIR is a Vienna-based non-profit research coordination organization that manages and disseminates EU-funded biomedical imaging projects for a pan-European network of 50+ academic institutions, industry partners, and imaging societies led by the European Society of Radiology.

Ownership category

akta.pro rank

Product category

Biomedical Research Coordination Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

Keywords

• Biomedical imaging research
• Research project coordination
• EU grant management
• Cancer imaging infrastructure
• Proposal writing services

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Network Service Packages and Industry Service Packages: Annual service agreements providing access to EIBIR's services including project coordination, proposal writing support, and dissemination network. Customers include academic institutions and industry partners in the biomedical imaging field. Packages are auto-renewed annually unless terminated by June 30.
2. EU Research Project Coordination: EIBIR coordinates and manages EU-funded research projects (e.g., EUCAIM, SOLACE, PreciseOnco), securing funding from the European Commission and its initiatives (Horizon Europe, EU4Health, IHI). Revenue is project-based funding for coordination activities.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

EIBIR is a non-profit research coordination organization that supports and coordinates biomedical imaging research projects across Europe. It provides project management, proposal writing, and dissemination services to research consortia, and coordinates EU-funded projects (such as EUCAIM, SOLACE, AI-POD, CLAUD-IT, CARE, HyperProbe, Med-IPUT, and ENDOMIX) under programs including Horizon Europe, EU4Health, and IHI. Customers include academic and research institutions, industry partners, and clinical imaging professionals in the biomedical imaging community.

Product overview

EIBIR (European Institute for Biomedical Imaging Research) is a research coordination organization that provides project management, proposal writing, and dissemination services for biomedical imaging research. The organization's portfolio includes multiple EU-funded research projects: EUCAIM (European Federation for Cancer Images) is a federated infrastructure platform for cancer imaging data sharing and AI development; SOLACE supports lung cancer screening implementation across Europe; AI-POD develops AI-driven cardiovascular risk prediction tools; CLAUD-IT and CARE focus on clinical audit and equipment standards; MARLIN addressed incident learning systems; HyperProbe and Med-IPUT develop innovative imaging technologies; and ENDOMIX studies endocrine-disrupting chemicals. EIBIR serves as an umbrella organization coordinating these initiatives under various EU funding programmes.

Differentiator

Problem solved

Functional benefit

Brands

• Pixel Pandemonium: An exhibit showcasing cutting-edge AI tools, platforms, and prototypes developed by researchers and innovators from across the medical imaging community at the European Congress of Radiology.
• Cancer Image Europe

Products and services

• Project Management Services Coordination and management of biomedical imaging research projects, freeing up researchers to focus on the science. Includes administrative, financial, and consortium management for EU-funded projects.
• Proposal Writing Services
• Dissemination and Communication Services
• Network Service Package
• Industry Service Package
• EUCAIM (European Federation for Cancer Images) A pan-European digital federated infrastructure platform for cancer-related, de-identified images that preserves data sovereignty of providers. Includes the Atlas of Cancer Images and provides a common platform for development and benchmarking of AI tools towards precision medicine. Serves clinicians, researchers, and AI developers across 14+ EU member states.
• SOLACE (Strengthening the Screening of Lung Cancer in Europe) An EU4Health project under Europe's Beating Cancer Plan that facilitates implementation of lung cancer screening programmes across Europe, providing a personalised toolbox to national and regional centres. Aims to reduce lung cancer deaths by 20% through LDCT screening implementation.
• AI-POD (AI for Prediction of Obesity-related Diseases) An AI-driven cardiovascular risk prediction project that integrates clinical, laboratory, and imaging data to develop an AI-based risk score, Clinical Decision Support System, and mobile citizen app for assessing obesity-related cardiovascular disease risk.
• CLAUD-IT (Clinical Audit Implementation in Europe) A 36-month EU4Health project focused on organisation of clinical audit campaigns to improve quality and safety of medical applications of ionising radiation in radiology and nuclear medicine across EU Member States.
• CARE (Criteria for Acceptability of Medical Radiological Equipment) A European Commission tender project updating criteria for acceptability of medical radiological equipment in diagnostic radiology, nuclear medicine and radiotherapy.
• HyperProbe A Horizon Europe project developing a compact, all-optical intraoperative imaging system for brain surgery that provides real-time brain tissue images with high specificity and sensitivity for cellular and molecular biomarkers.
• Med-IPUT (Medical Integrated Photonic Ultrasound Transducer)

Quantifiable outcome

• Better than average success rate in EU research proposal submissions
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Partnerships

17 partnerships are on record, tiered core and minor.

• Philips (Royal Philips)coreStrategic or Co-development Partner · 4 February 2026Philips coordinates the PreciseOnco research consortium, awarded €14.9 million in EU IHI funding. EIBIR supports/consortium involvement in the project. Philips is an industry partner contributing to five clinical studies focused on spectral imaging, robotic guidance, electrochemotherapy, and AI-guided integrated technologies for precision cancer care. Total project budget is €23.9 million.
• Quantum SurgicalcoreStrategic or Co-development Partner · 4 February 2026Quantum Surgical is an industry partner in the PreciseOnco consortium, contributing to precision cancer treatment research including robotic guidance and AI-powered technologies. The consortium has €23.9 million total budget over five years.
• IGEAcoreStrategic or Co-development Partner · 4 February 2026IGEA is an industry partner in the PreciseOnco consortium, participating in the five-year precision cancer treatment research program alongside Philips and Quantum Surgical, with clinical studies spanning Germany, Netherlands, and France.
• Academic institutions in Germany, Netherlands, and FrancecoreStrategic or Co-development Partner · 4 February 2026Academic institutions in Germany, Netherlands, and France participate as research partners in the PreciseOnco consortium, contributing to five clinical studies focused on spectral imaging, robotic guidance, electrochemotherapy, and AI-guided technologies for precision cancer care.
• EANM Research Ltd. (EARL)minorStrategic or Co-development Partner · 25 November 2024EARL (EANM Research Ltd.) is a consortium partner in the CARE project, working on updating criteria for acceptability of medical radiological equipment alongside EIBIR, EFOMP, and ESR.
• European Federation of Organisations for Medical Physics (EFOMP)minorStrategic or Co-development Partner · 1 September 2024EFOMP is a consortium partner in the CLAUD-IT and CARE projects, contributing expertise in medical physics for clinical audit implementation and criteria for acceptability of medical radiological equipment.
• European Association of Nuclear Medicine (EANM)minorStrategic or Co-development Partner · 1 September 2024EANM is a consortium partner in the CLAUD-IT and CARE projects, providing nuclear medicine expertise for clinical audit guidelines and radiation safety standards.
• European Society for Radiotherapy and Oncology (ESTRO)minorStrategic or Co-development Partner · 1 September 2024ESTRO provides scientific coordination for the MARLIN project, which aimed to improve reporting and learning from patient-related incidents in radiotherapy, interventional cardiology, nuclear medicine, and diagnostic/interventional radiology.
• Helmholtz Centre for Environmental Research (UFZ)minorStrategic or Co-development Partner · 1 January 2024UFZ coordinates the ENDOMIX project, exploring the impact of endocrine-disrupting chemicals on human health using interdisciplinary approaches and AI-assisted knowledge graphs, with 10 partners and €6.5 million funding.
• European Respiratory Society (ERS)coreStrategic or Co-development Partner · 1 April 2023ERS provides scientific leadership for the SOLACE project alongside ESR, supporting implementation of lung cancer screening programs across EU Member States under Europe's Beating Cancer Plan.
• European Society of Radiology (ESR)coreStrategic or Co-development Partner · 1 January 2023ESR is EIBIR's founding shareholder and primary institutional partner. EIBIR is established by and headquartered at ESR in Vienna. ESR provides the organizational backbone and professional radiology network that EIBIR leverages for research coordination and dissemination.
• European Cancer Imaging Initiative (EC)coreStrategic or Co-development Partner · 1 January 2023EUCAIM is the cornerstone of the European Commission-initiated European Cancer Imaging Initiative, a flagship of Europe's Beating Cancer Plan. The initiative aims to foster innovation in digital technologies for cancer treatment through a pan-European federated infrastructure of cancer-related de-identified images.
• AI for Health Imaging (AI4HI) NetworkcoreStrategic or Co-development Partner · 1 January 2023EUCAIM builds upon the results of the AI4HI Network, which consists of 5 large EU-funded projects on big data and AI in cancer imaging: Chaimeleon, EuCanImage, ProCancer-I, Incisive, and Primage. This established network provides the foundation for the cancer imaging data infrastructure.
• Medical University of Vienna (MUW)minorStrategic or Co-development Partner · 1 January 2023MUW coordinates the AI-POD project, developing AI-driven tools for cardiovascular risk prediction and clinical decision support for obesity-related diseases, with 13 partners and €5.3 million funding.
• Netherlands Organisation for Applied Scientific Research (TNO)minorStrategic or Co-development Partner · 1 January 2023TNO coordinates the Med-IPUT project, developing high-resolution medical ultrasound imaging using integrated photonic ultrasound transducer technology, with 5 partners and €2.5 million funding.
• European Health Data SpacecoreStrategic or Co-development Partner · 1 January 2023EUCAIM aligns with and supports the European Health Data Space initiative, partnering with the AI Testing and Experimentation Facility for Health under the Digital Europe Programme, enabling SME access to its infrastructure.
• Universita Degli Studi Di Firenze (UNIFI)minorStrategic or Co-development Partner · 1 October 2022UNIFI coordinates the HyperProbe project, developing an all-optical intraoperative imaging system for brain tumor surgery using hyperspectral imaging and AI, with 8 partners and €3.5 million funding.

Scale indicators5 records

Expansion highlights6 records

Broad incumbents

• Innovative Health Initiative (IHI): A public-private partnership between the European Commission and industry life-science associations (successor to IMI). EIBIR participates in IHI-funded consortia (e.g., PreciseOnco); IHI is comparable as a higher-level EU funding/coordination vehicle that intermediates research consortia with industry and academic partners.
• Cancer Research UK: The world's largest independent cancer research charity, funding and coordinating cancer research with a UK/global remit. Comparable to EIBIR as a major coordinator/funder of cancer-related research, though operating at a much larger scale, with commercial fundraising, and a UK rather than pan-European geographic base.
• EORTC (European Organisation for Research and Treatment of Cancer): A non-profit cancer clinical research organization that designs and coordinates multinational oncology trials. Broader in scope than EIBIR (covers all oncology, not just imaging) but directly comparable in operating model: non-profit, Europe-based, multi-stakeholder, EU-funded research coordination for cancer.

Direct peers

• BBMRI-ERIC (Biobanking and BioMolecular Resources Research Infrastructure): A European research infrastructure ERIC coordinating biobanks and biomolecular resources across member states. Directly comparable to EIBIR in operating model: pan-European, non-profit, EU-funded coordination of life-science research resources for academic and industry users.
• Euro-BioImaging ERIC: The European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences, a pan-European ERIC that coordinates imaging research infrastructure and services. Directly comparable to EIBIR as a publicly-funded, Europe-wide biomedical imaging coordination body that supports researchers with access, training and project management services.
• EATRIS (European Infrastructure for Translational Medicine): A European research infrastructure consortium providing translational medicine services to academic and industry researchers, with a similar non-profit coordination model and EU project portfolio. Comparable because it is a pan-European, multi-stakeholder research support organization funded through a mix of member fees and EU project grants.
• ECRIN (European Clinical Research Infrastructure Network): A pan-European infrastructure that provides project management, regulatory and trial coordination services for multinational clinical studies. Closely comparable to EIBIR's EU project coordination and proposal support model in the clinical research domain.
• ELIXIR: A European infrastructure for biological data, coordinating life-science data resources across member states. Comparable to EIBIR's role in EUCAIM (federated cancer imaging data infrastructure) and the broader coordination of data-sharing services for European life-science research.

Others

• European Respiratory Society (ERS): Co-lead (with ESR) of the SOLACE lung cancer screening project and a major European medical society. Comparable as a sister society in EIBIR's partnership network, and adjacent in the broader European research-coordination ecosystem, though it is not a research coordination infrastructure in the way EIBIR is.
• European Society of Radiology (ESR): EIBIR's founding shareholder and host organization. Not a direct competitor — instead ESR is the upstream professional society that EIBIR is built to serve; included because it is the most important institutional counterpart and is referenced in nearly every part of EIBIR's value proposition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/eibir_biomed
• LinkedInlinkedin.com/company/eibir
• Facebookfacebook.com/EIBIR.biomed

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The European Institute for Biomedical Imaging Research